 |
Printer Friendly
Printed from http://www.researchandmarkets.com/reports/45272
The Pharmaceutical Market: Morocco
|
Description: |
THE PHARMACEUTICAL MARKET: MOROCCO - REVIEW
The Moroccan economy is expected to grow by a moderate CAGR in US dollar terms between 2011 and 2016. The national health insurance scheme (AMO) is expected to provide substantial additional funding for the health sector. Initially aimed at salaried workers, the scheme has been expanded to cover the self-employed. The CNSS, which operates the scheme in the private sector, announced that it would be extending cover to ambulatory care, in addition to hospital treatment. A health insurance scheme for those on very low incomes is still in the early stages of implementation and is expected to be rolled out on a national basis in 2011.
Although the Moroccan pharmaceutical market is small in global terms, per capita spending on pharmaceutical products is comparatively high for an African country, where average per capita income is just above US$3,000. The pharmaceutical market, which was stagnating prior to the launch of the universal health insurance scheme in 2006, is expected to grow by a moderate CAGR between 2011 and 2016. Around 2,600 drugs are eligible for reimbursement under the national health insurance scheme. Reimbursement is made on the basis of the retail price of generic products, where these exist. The government cut drug prices and encouraged generic consumption in 2010, following a parliamentary report published in 2009.
Over 50% of the pharmaceutical companies operating in the country are owned by foreign interests, and these companies are responsible for more than half of industry turnover. Multinationals with a strong presence in the Moroccan pharmaceutical market include Sanofi, GlaxoSmithKline and Pfizer. Hikma is also expected to increase its market penetration, following its acquisition of 63.9% of Promopharm, announced in October 2011. Independent local manufacturers primarily manufacture under licence or produce generics. Leading indigenous producers include Cooper Pharma, Laprophan and Sothéma. In September 2010, Cooper Pharma signed a technology transfer agreement with the Taiwanese Orient Europharma (OE) for the production of two medicaments developed for the treatment of sleeping disorders and diabetes.
ENHANCED STRATEGIC INTELLIGENCE
These highly regarded world pharmaceutical market reports have been redesigned to provide enhanced strategic intelligence in a user-friendly format. Each report provides in-depth information, setting the pharmaceutical market in context. The reports provide:
- Five-year projections for economic, demographic, health expenditure, health workforce and pharmaceutical market indicators.
- Specialised intelligence on OTCs, generics, biologics and biosimilars.
- Exclusive economic and demographic data from the Economist Intelligence Unit (EIU) for each market in the series.
- A separate statistical health file, comprising health expenditure, health infrastructure, health services and health personnel.
- The reports are updated quarterly, providing you with the latest information for a full year. In addition, the service will keep you up to date with market and industry news on a regular basis.
HEALTHCARE STATISTICS
A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included. |
|
Contents: |
HEALTHCARE STATISTICS
A comprehensive tabula review, comprising demographics, epidemiology, health expenditure, hospital and primary care infrastructure & services and healthcare personnel, is additionally included.
EXECUTIVE SUMMARY
Including Espicom's at a glance strategic analysis and key data projections
MACROENVIRONMENT
Political, economic, legal and demographic analysis
EPIDEMIOLOGY
Disease burden and prevalence
HEALTHCARE
Organisation, expenditure, infrastructure, services and workforce
REGULATORY AFFAIRS
Regulatory developments and marketing registration/authorisation
PRICING & REIMBURSEMENT
DISTRIBUTION CHANNELS
MARKET ANALYSIS
Projections, product development, manufacturing and trade
COMPETITION
Trade associations, trade fairs, company intelligence and competitive strategies
OTC PHARMACEUTICALS
GENERIC PHARMACEUTICALS
BIOLOGICS & BIOSIMILARS
OPPORTUNITIES & CHALLENGES
Espicom's unique strategic analysis
DIRECTORY
METHODOLOGY & SOURCES |
|
Companies Mentioned |
- Laboratoire Afric-Phar
- Bottu
- Cooper Maroc
- Laboratoire Galenica
- Iberma
- Laprophan
- Pharmaceutical Institute
- Polymedic
- Promopharm
- Sothéma
- Bayer Pharma Maroc
- GlaxoSmithKline
- Pfizer
- Sanofi-Aventis
- Servier
- Cooper Maroc
- Sophasud |
|
Ordering: |
Order Online - visit http://www.researchandmarkets.com/reports/45272
Order by Fax - using the order form below
Order By Post - print the order form below and send to
|
|
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
 |
Page 1 of 2
Printed 13/02/2012 08:04:27 |
|
Fax Order Form
To place an order via fax simply print this form, fill in the information below and
fax the completed form to
646-607-1907 (from USA) or +353 1 6849977 (from Rest of World). If you have any questions please email help@researchandmarkets.net
Order information
Please verify that the product information is correct and select the format you require.
|
|
|
|
Product Name: |
The Pharmaceutical Market: Morocco
|
|
Web Address: |
http://www.researchandmarkets.com/reports/45272
|
|
Office Code: |
|
OC8IHINLSNNSS
|
Report formats
Please enter the quantity of the report format you require.
|
|
Format
|
Quantity
|
Price
|
|
Electronic (Online Access)
- Enterprisewide
|
|
€5,050.00
|
|
Electronic (PDF)
- Enterprisewide
|
|
€5,050.00
|
|
Electronic (Online Access)
- Single User
|
|
€775.00
|
|
Hard Copy
|
|
€775.00 + EUR€ 50.00 Shipping/Handling *
|
|
Electronic (PDF)
- Single User
|
|
€775.00
|
* Shipping/Handling is only charged once per order.
Contact information
Please enter all the information below in BLOCK CAPITALS.
|
|
|
First Name: |
Last Name: |
|
Email Address: |
|
|
Job Title: |
|
|
Organisation: |
|
|
Address: |
|
|
City: |
|
|
Postal/Zip Code: |
|
|
Country: |
|
|
Phone Number: |
|
|
Fax Number: |
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
Page 2 of 2
Printed 13/02/2012 08:04:27
|
|
Payment information
Please indicate the payment method you would like to use by selecting the appropriate
box.
|
|
|
|
|
American Express
|
|
|
Diners Club
|
|
|
Master Card
|
|
|
Visa
|
|
|
|
|
|
|
Cardholder's Name: |
|
|
|
|
Cardholder's Signature: |
|
|
|
|
Expiry Date: |
/ |
|
|
|
Card Number: |
|
|
|
|
CVV Security Code: |
|
|
|
|
Issue Date: |
/ (Diners
Club only)
|
|
|
|
|
|
|
Please post the check, accompanied by this form, to:
Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.
|
|
|
|
|
|
|
Please transfer funds to:
|
|
|
Account number: |
83313083 |
|
Sort code: |
98-53-30 |
|
Swift code: |
ULSBIE2D |
|
IBAN number: |
IE78ULSB98533083313083 |
|
Bank Address: |
Ulster Bank,
27-35 Main St,
Blackrock,
Co. Dublin,
Ireland. |
|
|
|
If you have a Marketing Code please enter it below:
|
|
|
Marketing Code: |
|
|
Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp
|
|
Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)
|
|
|
|
|
|
